← Back to headlines
Goldman Sachs Updates Stock Price Targets for Figma and Biogen
Goldman Sachs has announced updated stock price targets for both Figma and Biogen. The financial institution revised Figma's target through 2026 and established a new target for Biogen, influenced by its outlook on Alzheimer's research.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
Amazon's First Customer Receipt Goes Viral, Bezos and Musk React
just now
Central Visayas Experiences Sharpest Cost of Living Increase in Philippines
just now
Misamis Oriental Steel Plant Faces Closure After Raid and Arrests
just now
69 Chinese Nationals Arrested in Raid on Misamis Oriental Steel Plant
just now